Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Lung Neoplasms and RAD51[original query] |
|---|
| Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy. Cancer chemotherapy and pharmacology 2010 Aug 66 (3): 501-6. Nogueira Augusto, Catarino Raquel, Coelho Ana, Araújo António, Gomes Mónica, Medeiros R |
| Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PloS one 2011 6 (5): e20055. Yin Ming, Liao Zhongxing, Huang Yu-Jing, Liu Zhensheng, Yuan Xianglin, Gomez Daniel, Wang Li-E, Wei Qing |
| [The study of esophageal cancer risk associated with polymorphisms of DNA damage repair genes XRCC4 and RAD51]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2013 Jul 44 (4): 568-72. Fan Xue-Jiao, Ren Peng-Liang, Lu Zhong-Jiao, Zhao Shu, Yang Xiao-Long, Liu J |
| The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer. Medical oncology (Northwood, London, England) 2014 May 31 (5): 959. Jiang You-Hua, Xu Xiao-Ling, Ruan Hai-Hong, Xu Wei-Zhen, Li Dan, Feng Jian-Guo, Han Qian-Bo, Mao Wei-M |
| TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool. Journal of clinical pathology 2018 11 72 (1): 75-80. Cavic Milena, Spasic Jelena, Krivokuca Ana, Boljevic Ivana, Kuburovic Mira, Radosavljevic Davorin, Jankovic Radmi |
| EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report. Lung cancer (Amsterdam, Netherlands) 2018 1 115 131-134. Zhu You-Cai, Wang Wen-Xian, Xu Chun-Wei, Song Zheng-Bo, Du Kai-Qi, Chen Gang, Lv Tang-Feng, Song Yo |
| KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma. OncoTargets and therapy 2020 9 13 8317-8321. Xu Hui, Shao Chu |
| Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Science translational medicine 2021 1 13 (578): . Tlemsani Camille, Takahashi Nobuyuki, Pongor Lorinc, Rajapakse Vinodh N, Tyagi Manoj, Wen Xinyu, Fasaye Grace-Ann, Schmidt Keith T, Desai Parth, Kim Chul, Rajan Arun, Swift Shannon, Sciuto Linda, Vilimas Rasa, Webb Santhana, Nichols Samantha, Figg William Douglas, Pommier Yves, Calzone Kathleen, Steinberg Seth M, Wei Jun S, Guha Udayan, Turner Clesson E, Khan Javed, Thomas Ani |
- Page last reviewed:Feb 1, 2024
- Content source: